Treatment With Amifostine, Topotecan And Cytarabine In 31 Consecutive Patients With High Risk Myelodysplastic Syndrome: A Phase Ii Trial.

BLOOD(2004)

Cited 23|Views11
No score
Abstract
Myelodysplastic syndromes are an heterogenous group of malignancies with a poor outcome. In order to improve the response rates and to prolong survival, many trials have been conducted including new scoring systems and using combination of new drugs.
More
Translated text
Key words
high risk myelodysplastic syndrome,cytarabine,amifostine,topotecan
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined